BayMark Health Services acquired Limestone Health, an opioid treatment provider organization with locations in Bloomington and Lafayette, Indiana, formerly owned by Springstone, Inc. Limestone provides outpatient medication-assisted treatment (MAT) with methadone services including medication management, addiction counseling, and education. The programs will fall under BayMark’s MedMark Treatment Centers brand.
Providing MAT and a full suite of other substance abuse services in locations across the country, BayMark is an established, trusted provider of comprehensive treatment for opioid addiction. Limestone Health shares BayMark’s commitment to providing high quality, individualized treatment for those struggling with an opioid addiction, making it a perfect fit for expansion into Indiana.
In addition to methadone maintenance treatment (MMT) and counseling, services will also include addiction and relapse education, coordinated treatment during pregnancy, in-house lab services and referrals to community resources to assist people in rebuilding their lives. Methadone, combined with counseling and support services, is known as the gold standard in the treatment of opioid addiction.
BayMark Health Services provides medication-assisted treatment to 57,000+ people in recovery from addiction disorders across the United States and Canada. BayMark services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy and inpatient detoxification services are offered for a variety of addiction disorders.
This was reported by Baymark Health Services on November 19, 2020.
Contact information: Baymark Health Services, 1720 Lakepointe, Dr. Suite 117, Lewisville, TX 75057; 214-379-3300; Website: https://baymark.com/